Clinical trial to start soon on GSK Ebola vaccine;Company Involved in Clinical EBOLA Trial GSK Vaccine Has History of Corruption
http://uk.reuters.com/article/2014/08...
(Reuters) - A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists.
The world's worst outbreak of Ebola has killed nearly 1,000 people in West Africa and the disease could continue spreading for months, increasing pressure on researchers to accelerate their work on new medical interventions.
No comments:
Post a Comment